Abstract

Introduction

At the end of the treatment, many young breast cancer (BC) survivors face difficulties related to fertility and sexuality, mainly due to the side effects of treatment. Integrating patient needs into medical decisions is becoming increasingly essential for high quality care. To this end, there is a compelling need to elicit patients’ perspectives through qualitative studies, to understand their experiences and needs in the aftermath of cancer. We aim to: (1) identify clinical, social and economic determinants of sexuality and fertility, and describe other living conditions of young BC survivors in France; and (2) explore young women’s experience after BC in relation to clinical and information needs about fertility preservation and sexual health.

Methods and analysis

This is a mixed-methods, cross-sectional, population-based study. In the quantitative component, women diagnosed with non-metastatic BC between 2009 and 2016 and aged 40 years or younger at diagnosis will be identified through the French network of cancer registries (FRANCIM). Participants will complete self-report questionnaires including standardised measures of sexuality, health-related quality of life (HRQoL), anxiety, depression, social deprivation and social support. Fertility and professional reintegration issues will also be assessed. Sexuality profiles will be identified by ascending hierarchical classification and fertility profiles will be identified by latent class models. Determinants of sexuality, fertility and HRQoL will be identified using a mixed regression model. Subsequently, semistructured interviews will be performed with a sample of 30 women who participated in the quantitative study. Interviews will be recorded, transcribed synthetically and content analysis will be performed, with the aid of NVivo software.

Ethics and dissemination

This study will be performed in accordance with the declaration of Helsinki. The protocol was approved in October 2020 by the Committee for the Protection of Persons North-West III (20.07.16.44445) and by the French national data protection authority (CNIL-MR003 No1989764-v0).

The results of this project will be communicated to the scientific community through publications in international scientific peer-reviewed journals and communications to national and international congresses. Popularised results will also be provided to patient associations. The results of Candy project will also be published on the website of the sponsor, www.cgfl.fr.

Details

Title
Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocol
Author
Emerline L F Assogba 1 ; Dumas, Agnès 2 ; Woronoff, Anne-Sophie 3 ; Mollévi, Caroline 4 ; Coutant, Charles 5 ; Ladoire, Sylvain 6 ; Desmoulins, Isabelle 7 ; Tienhan, Sandrine Dabakuyo-Yonli 8   VIAFID ORCID Logo 

 Breast and Gynaecologic Cancer Registry of Côte d’Or, Epidemiology and Quality of Life Research Unit, Georges François Leclerc Comprehensive Cancer Centre - UNICANCER, Dijon, Bourgogne-Franche-Comté, France; Lipids, Nutrition, Cancer Research Center, French National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale [INSERM]) U1231, Dijon, Bourgogne-Franche-Comté, France 
 Clinical Epidemiology and Economic Evaluation Applied to Vulnerable Populations (Epidémiologie Clinique et Évaluation Économique appliquée aux Populations Vulnérables [ECEVE])—INSERM UMR 1123, University of Paris, Paris, Île-de-France, France 
 Cancer Registry of Doubs, Besançon Regional University Hospital Centre, Besançon, Bourgogne-Franche-Comté, France; EA3181, Burgundy Franche-Comté University, Besançon, Bourgogne-Franche-Comté, France 
 Biometrics Unit, Montpellier Cancer Research Institute, Montpellier, Languedoc-Roussillon-Midi-Pyrénées, France; University of Montpellier, Montpellier, Languedoc-Roussillon-Midi-Pyrénées, France 
 Department of Surgical Oncology, Georges François Leclerc Comprehensive Cancer Centre - UNICANCER, Dijon, Bourgogne-Franche-Comté, France; Faculty of Medicine and Pharmacy, Burgundy Franche-Comté University, Dijon, Bourgogne-Franche-Comté, France 
 Medical Oncology Unit, Georges François Leclerc Comprehensive Cancer Centre - UNICANCER, Dijon, Bourgogne-Franche-Comté, France; Chemotherapy and Immune Response Team, Lipides Nutrition Cancer, Dijon, Bourgogne-Franche-Comté, France 
 Medical Oncology Unit, Georges François Leclerc Comprehensive Cancer Centre - UNICANCER, Dijon, Bourgogne-Franche-Comté, France 
 Breast and Gynaecologic Cancer Registry of Côte d’Or, Epidemiology and Quality of Life Research Unit, Georges François Leclerc Comprehensive Cancer Centre - UNICANCER, Dijon, Bourgogne-Franche-Comté, France; Lipids, Nutrition, Cancer Research Center, French National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale [INSERM]) U1231, Dijon, Bourgogne-Franche-Comté, France; National Quality of Life and Cancer Clinical Research Platform, Dijon, Bourgogne-Franche-Comté, France 
First page
e056834
Section
Oncology
Publication year
2022
Publication date
2022
Publisher
BMJ Publishing Group LTD
e-ISSN
20446055
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2723676308
Copyright
© 2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:  http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.